Understanding ALCHEMIST Results, with Patrick Rossignol, MD, PhD
Patrick Rossignol, MD, PhD, provides additional perspective on the results of the ALCHEMIST trial from Kidney Week 2023.
Stay updated with breaking news from Paper Presented. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Patrick Rossignol, MD, PhD, provides additional perspective on the results of the ALCHEMIST trial from Kidney Week 2023.
Preliminary data from the open-label RUBY-3 trial were presented at the American Society of Nephrology Kidney Week 2023.
Analysis of nearly 15k patients with non-dialysis-dependent CKD and anemia provides insight into contemporary trends in management.
Data from multiple presentations at ASN Kidney Week 2023 offer insight into the effects of atacicept in patients with IgA nephropathy as well as the design of the phase 3 trial, which is currently enrolling.
Data for a pair of studies presented at Kidney Week 2023 provide an overview of the effects of eGFR and how this might translate to potential long-term benefit in patients IgA nephropathy.